EP4472642A4 - HETEROCYCLIC DERIVATIVES OF PURIC CYTOKININES, THEIR USE IN WOUND HEALING AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE DERIVATIVES - Google Patents

HETEROCYCLIC DERIVATIVES OF PURIC CYTOKININES, THEIR USE IN WOUND HEALING AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE DERIVATIVES

Info

Publication number
EP4472642A4
EP4472642A4 EP22889496.0A EP22889496A EP4472642A4 EP 4472642 A4 EP4472642 A4 EP 4472642A4 EP 22889496 A EP22889496 A EP 22889496A EP 4472642 A4 EP4472642 A4 EP 4472642A4
Authority
EP
European Patent Office
Prior art keywords
derivatives
heterocyclical
purin
pharmaceutical compositions
compositions containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP22889496.0A
Other languages
German (de)
English (en)
French (fr)
Other versions
EP4472642A1 (en
Inventor
Lucie Rárová
Olga Hustáková
Karel Dolezal
Miroslav Strnad
Václav Mik
Marek Zatloukal
Ondrej Novák
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Palacky University Olomouc
Original Assignee
Palacky University Olomouc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Palacky University Olomouc filed Critical Palacky University Olomouc
Publication of EP4472642A1 publication Critical patent/EP4472642A1/en
Publication of EP4472642A4 publication Critical patent/EP4472642A4/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP22889496.0A 2022-01-31 2022-02-02 HETEROCYCLIC DERIVATIVES OF PURIC CYTOKININES, THEIR USE IN WOUND HEALING AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE DERIVATIVES Pending EP4472642A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CZ2022-44A CZ310053B6 (cs) 2022-01-31 2022-01-31 Heterocyklické purinové deriváty cytokininů, jejich použití při hojení ran a farmaceutické kompozice obsahující tyto deriváty
PCT/CZ2022/050010 WO2023078482A1 (en) 2022-01-31 2022-02-02 Heterocyclic purine cytokinin derivatives, their use in wound healing and pharmaceutical compositions containing these derivatives

Publications (2)

Publication Number Publication Date
EP4472642A1 EP4472642A1 (en) 2024-12-11
EP4472642A4 true EP4472642A4 (en) 2025-11-26

Family

ID=86240708

Family Applications (1)

Application Number Title Priority Date Filing Date
EP22889496.0A Pending EP4472642A4 (en) 2022-01-31 2022-02-02 HETEROCYCLIC DERIVATIVES OF PURIC CYTOKININES, THEIR USE IN WOUND HEALING AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE DERIVATIVES

Country Status (3)

Country Link
EP (1) EP4472642A4 (cs)
CZ (1) CZ310053B6 (cs)
WO (1) WO2023078482A1 (cs)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030206893A1 (en) * 2002-05-06 2003-11-06 Sohail Malik Cell proliferating agents
WO2005020892A2 (en) * 2003-08-08 2005-03-10 Mitochroma Research, Inc. Pharmaceutical compositions and methods for metabolic modulation
US7960397B2 (en) * 2007-12-28 2011-06-14 Institute Of Experimental Botany, Academy Of Sciences Of The Czech Republic 6,9-disubstituted purine derivatives and their use as cosmetics and cosmetic compositions

Also Published As

Publication number Publication date
CZ310053B6 (cs) 2024-06-19
EP4472642A1 (en) 2024-12-11
WO2023078482A1 (en) 2023-05-11
CZ202244A3 (cs) 2023-08-09

Similar Documents

Publication Publication Date Title
BR0315580A (pt) Derivados de metileno uréia
ECSP055680A (es) Nuevos compuestos de imidazol como inhibidores del factor de crecimiento transformante (tgf)
BRPI0507198A (pt) derivados de bisariluréia
ECSP055681A (es) Nuevos compuestos de triazol como inhibidores del factor de crecimiento transformante (tgf)
UY28441A1 (es) Derivados de quinazolina
UY28691A1 (es) Derivados de difenilazetidona
EA200700902A1 (ru) 3-ариламинопиридиновые производные
ATE486860T1 (de) Phenothiazin-derivat zur wundheilung
DE602005016929D1 (de) Liganden für den cannabinoidrezeptoren
DE60206911D1 (de) Imidazol-2-carbonsäureamid derivate als raf-kinase-inhibitoren
UY28940A1 (es) Derivados de quinazolina
CY1106386T1 (el) Υποκατεστημενα παραγωγα 3-πυρρολιδιν-ινδολης
NO20084328L (no) Nye forbindelser
BRPI0713755A8 (pt) composto ou um sal ou solvato do mesmo, uso do composto ou um sal ou salvato do mesmo, composição farmacêutica,e, processo para a preparação de um composto ou um sal ou solvato do mesmo
EA200870254A1 (ru) Способ лечения воспалительных заболеваний
EP4397663A4 (en) 6-AMINOPYRAZOLOPYRIMIDINE COMPOUND AND ITS PHARMACEUTICAL USE
ATE487720T1 (de) 5,6,7,8-tetrahydropteridin-derivate als hsp90- hemmer
Ponnusamy et al. Activation of sirtuin-1 promotes renal fibroblast activation and aggravates renal fibrogenesis
CO2022000749A2 (es) Inhibidores de monoacilglicerol lipasa (magl) heterocíclicos
SA522441639B1 (ar) Egfr مثبطات تفارغية وطرق استخدامها
EP4008718C0 (en) HETEROARYLAMIDOPYRIDINOL DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING IT AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING AUTOIMMUNE DISEASE
BRPI0515991A (pt) derivados de bisariluréia substituìda heterocìclica como inibidores de cinase
EP4223759C0 (en) PYRAZOLOPYRIDAZINONE COMPOUND, PHARMACEUTICAL COMPOSITION CONTAINING IT AND ITS USE
EP4375300A4 (en) PHARMACEUTICAL COMPOSITION AND ITS USE
EA200401319A1 (ru) Новые гетероциклические соединения, способы их получения и фармацевтические композиции, содержащие эти соединения, и их использование в медицине

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20240816

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)